ArticleJournal of gastrointestinal cancer2024

Prolonged Response to Dabrafenib/Trametinib in Grade 3 Metastatic Pancreatic Neuroendocrine Tumor (NET G3) with BRAF V600E Mutation.

Benjamin E Ueberroth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.